This Website is not fully compatible with Internet Explorer.
For a more complete and secure browsing experience please consider using Microsoft Edge, Firefox, or Chrome

Advancing Regulatory Science and In Silico Medicine at the FDA

This Presentation, Advancing Regulatory Science and In Silico Medicine at the FDA, is from 2017. NAFEMS & ASSESS members can view / download when logged in.

The ASSESS Initiative is a broad reaching multi-industry initiative with a primary goal to facilitate a revolution of enablement that will vastly increase the availability and utility of Engineering Simulation, leading to significantly increased business benefits across the full spectrum of industries, applications and users. Since June 2022, ASSESS as been part of NAFEMS.

Document Details

Referencearsaismatfda
AuthorMorrison. T
LanguageEnglish
TypePresentation
Date 30th October 2017
OrganisationUSFDA (U.S. Food and Drug Administration)
RegionGlobal

Download


Back to Previous Page